Brief: Vaxil Says Will Continue To Pursue Convertible Debt Financing With Amended Terms
Feb 21 (Reuters) - Vaxil Bio Ltd VXL.V :
* VAXIL ANNOUNCES FINANCING UPDATE
* VAXIL - WILL CONTINUE TO PURSUE CONVERTIBLE DEBT FINANCING
WITH
AMENDED TERMS
Source text for Eikon: ID:nGNX99rzGT
Further company coverage: VXL.V
(Reuters.Briefs@thomsonreuters.com)
Recent news on Vaxil Bio
See all newsBrief: Vaxil Announces Close Of Previously Announced Non-Brokered Private Placement
Brief: Vaxil Bio Says Proposed Reverse Takeover With Green Date Terminated
Brief: Vaxil Bio Enters Into Definitive Agreement With Green Data Centers for Reverse Take Over
Brief: Vaxil Bio To Continue Actively Explore Other Strategic Options
Brief: Vaxil Bio Enters Into Letter Of Intent With Copper Bullet Mines In Respect Of A Proposed Reverse Takeover